These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26621834)

  • 1. Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals.
    Shang Z; Lv H; Zhang M; Duan L; Wang S; Li J; Liu G; Ruijie Z; Jiang Y
    Oncotarget; 2015 Dec; 6(40):42504-14. PubMed ID: 26621834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
    Lv H; Zhang M; Shang Z; Li J; Zhang S; Lian D; Zhang R
    Oncotarget; 2017 Jan; 8(5):7891-7899. PubMed ID: 27903959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals.
    Tycko B; Lee JH; Ciappa A; Saxena A; Li CM; Feng L; Arriaga A; Stern Y; Lantigua R; Shachter N; Mayeux R
    Arch Neurol; 2004 Sep; 61(9):1434-9. PubMed ID: 15364690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of recessive Alzheimer disease loci in a Caribbean Hispanic data set: genome-wide survey of runs of homozygosity.
    Ghani M; Sato C; Lee JH; Reitz C; Moreno D; Mayeux R; St George-Hyslop P; Rogaeva E
    JAMA Neurol; 2013 Oct; 70(10):1261-7. PubMed ID: 23978990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
    Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
    J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide haplotype association study identifies BLM as a risk gene for prostate cancer in Chinese population.
    Wang Q; Lv H; Lv W; Shi M; Zhang M; Luan M; Zhu H; Zhang R; Jiang Y
    Tumour Biol; 2015 Apr; 36(4):2703-7. PubMed ID: 25472581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
    Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
    Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accounting for linkage disequilibrium among markers in linkage analysis: impact of haplotype frequency estimation and molecular haplotypes for a gene in a candidate region for Alzheimer's disease.
    Sieh W; Yu CE; Bird TD; Schellenberg GD; Wijsman EM
    Hum Hered; 2007; 63(1):26-34. PubMed ID: 17215579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12.
    Luedecking-Zimmer E; DeKosky ST; Chen Q; Barmada MM; Kamboh MI
    Hum Genet; 2002 Oct; 111(4-5):443-51. PubMed ID: 12384789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease.
    Lambert JC; Grenier-Boley B; Harold D; Zelenika D; Chouraki V; Kamatani Y; Sleegers K; Ikram MA; Hiltunen M; Reitz C; Mateo I; Feulner T; Bullido M; Galimberti D; Concari L; Alvarez V; Sims R; Gerrish A; Chapman J; Deniz-Naranjo C; Solfrizzi V; Sorbi S; Arosio B; Spalletta G; Siciliano G; Epelbaum J; Hannequin D; Dartigues JF; Tzourio C; Berr C; Schrijvers EM; Rogers R; Tosto G; Pasquier F; Bettens K; Van Cauwenberghe C; Fratiglioni L; Graff C; Delepine M; Ferri R; Reynolds CA; Lannfelt L; Ingelsson M; Prince JA; Chillotti C; Pilotto A; Seripa D; Boland A; Mancuso M; Bossù P; Annoni G; Nacmias B; Bosco P; Panza F; Sanchez-Garcia F; Del Zompo M; Coto E; Owen M; O'Donovan M; Valdivieso F; Caffarra P; Scarpini E; Combarros O; Buée L; Campion D; Soininen H; Breteler M; Riemenschneider M; Van Broeckhoven C; Alpérovitch A; Lathrop M; Trégouët DA; Williams J; Amouyel P
    Mol Psychiatry; 2013 Apr; 18(4):461-70. PubMed ID: 22430674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of genetic variation in LRRTM3 on risk of Alzheimer disease.
    Reitz C; Conrad C; Roszkowski K; Rogers RS; Mayeux R
    Arch Neurol; 2012 Jul; 69(7):894-900. PubMed ID: 22393166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymorphism in SOD2 is associated with development of Alzheimer's disease.
    Wiener HW; Perry RT; Chen Z; Harrell LE; Go RC
    Genes Brain Behav; 2007 Nov; 6(8):770-5. PubMed ID: 17376152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease.
    Lee JH; Cheng R; Rogaeva E; Meng Y; Stern Y; Santana V; Lantigua R; Medrano M; Jimenez-Velazquez IZ; Farrer LA; St George-Hyslop P; Mayeux R
    Neurogenetics; 2008 May; 9(2):127-38. PubMed ID: 18340469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population.
    Verpillat P; Bouley S; Campion D; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Antérion C; Agid Y; Brice A; Clerget-Darpoux F
    Eur J Hum Genet; 2001 Jun; 9(6):464-8. PubMed ID: 11436129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMBP is genetically associated with Alzheimer dementia in the Belgian population.
    Bettens K; Brouwers N; Engelborghs S; De Pooter T; De Deyn PP; Sleegers K; Van Broeckhoven C
    Neurobiol Aging; 2009 Dec; 30(12):2000-9. PubMed ID: 18359537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide haplotype association analysis identifies SERPINB9, SERPINE2, GAK, and HSP90B1 as novel risk genes for oral squamous cell carcinoma.
    Sun W; Lv W; Lv H; Zhang R; Jiang Y
    Tumour Biol; 2016 Feb; 37(2):1845-51. PubMed ID: 26318431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha7 nicotinic acetylcholine receptor gene and reduced risk of Alzheimer's disease.
    Carson R; Craig D; McGuinness B; Johnston JA; O'Neill FA; Passmore AP; Ritchie CW
    J Med Genet; 2008 Apr; 45(4):244-8. PubMed ID: 18057084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer's disease in Caribbean Hispanics.
    Horimoto ARVR; Xue D; Thornton TA; Blue EE
    Alzheimers Res Ther; 2021 Jul; 13(1):122. PubMed ID: 34217363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease.
    Feuk L; Prince JA; Blennow K; Brookes AJ
    Hum Mutat; 2003 Jan; 21(1):53-60. PubMed ID: 12497631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.